| 1 | Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2015 Feb;19(103):109-16 16 Citations |
| 1 | Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis. (Schmidt JW, Wehde BL, Sakamoto K, Triplett AA, Anderson SM, Tsichlis PN, Leone G, Wagner KU) Mol Cell Biol 2014 Apr;34(7):1363-77 63 Citations |
| 1 | PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. (Kurek KC, Howard E, Tennant LB, Upton J, Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP) Am J Surg Pathol 2012 May;36(5):671-87 111 Citations |
| 1 | Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation. (Iacobas I, Burrows PE, Adams DM, Sutton VR, Hollier LH, Chintagumpala MM) Pediatr Blood Cancer 2011 Aug;57(2):321-3 75 Citations |
| 1 | Morphologic characterization of syndromic gastric polyps. (Lam-Himlin D, Park JY, Cornish TC, Shi C, Montgomery E) Am J Surg Pathol 2010 Nov;34(11):1656-62 51 Citations |
| 1 | The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. (Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB, Fishman SJ, Irons MB) J Med Genet 2007 Sep;44(9):594-602 269 Citations |
